Clinical Trials Browser

Unknown × INDUSTRY × Clear all

NCT01107522 2025-09-09

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Phase 1 Unknown

Glioblastoma, Glioma

NCT05735704 2025-03-26

SANGUINE

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms

NCT04637763 2025-03-24

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

Phase 1 Unknown

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT02716012 2025-03-10

OUTREACH

Phase 1 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06440018 2025-02-21

INSPIRE

BreastGastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06371534 2025-02-11

A Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPRO® in Healthy Adults

Phase 1 Unknown

Neoplasms

NCT06237257 2024-12-24

A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer

Phase 2 Unknown

Locally Advanced Cervical Cancer

NCT06254807 2024-12-19

CAR-monocytes for the Treatment of HER2 Overexpressing Solid Tumors

Phase 1 Unknown

HER2-positive

NCT04660929 2024-12-18

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Phase 1 Unknown

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Carcinoma, Ovarian Epithelial, Adenocarcinoma, Bile Duct Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Small Cell, Carcinoma, Ductal, Small Cell Lung Carcinoma, Inflammatory Breast Neoplasms

NCT06724835 2024-12-09

Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)

Phase 1 Unknown

Advanced Breast Cancer

NCT05650242 2024-11-08

A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1106 in Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumors

NCT06410703 2024-10-31

CAN1012 Combined With PD-1 in Patients With Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Advanced Solid Tumor

NCT04977167 2024-10-10

Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma

Phase 1 Unknown

Lymphoma

NCT06196762 2024-10-10

Phase I of XKH002 Injection in Patients

Phase 1 Unknown

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT05830097 2024-08-26

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

BreastGastrointestinalThoracic

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT06149169 2024-08-21

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma

Phase 2 Unknown

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT06564363 2024-08-21

The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Recurrence

NCT06553859 2024-08-14

SCderm

Breast Cancer Female

NCT06353360 2024-08-09

TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.

Phase 2 Unknown

Glioblastoma

NCT06541405 2024-08-07

Safety and Efficacy of NK520 to Treat Pediatric Relapsed/Refractory Acute Myeloid Leukemia

Phase EARLY_PHASE1 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05076552 2024-08-01

A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic Cancer

Phase 1 Unknown

Neoplasm Metastasis, Neoplasms

NCT06533605 2024-08-01

Phase I Clinical Study to Evaluate the Safety and Efficacy of SSGJ-706 Monotherapy for Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Advanced Solid Tumors Patients

NCT06128694 2024-07-30

Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients

Phase 3 Unknown

GynecologicThoracic

Uterine Cervical Neoplasms, Kwashiorkor, Lung Neoplasms, Neoplasms, Malnutrition

NCT06526832 2024-07-30

A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer

Phase 1 Unknown

Locally Advanced Liver Carcinoma

NCT06199908 2024-07-26

AMT-562 in Patients With Selected Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Advanced Solid Tumors

NCT06237491 2024-07-24

The Safety and Dosimetry Study of 177Lu-LNC1003 Injection

Phase 1 Unknown

Metastatic Castration-resistant Prostate Cancer, mCRPC

NCT06256055 2024-07-24

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

Phase 1 Unknown

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Bile Duct Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT06507332 2024-07-18

Combination Letrozole and Clomiphene Citrate Versus Letrozole Alone

Phase NA Unknown

Polycystic Ovary Syndrome

NCT06413745 2024-07-08

Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression / Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract Cancer

Phase 2 Unknown

Gastrointestinal

HER2 Expression / Amplification in Patients With Biliary Tract Cancer

NCT05181826 2024-06-14

ELITE

Diabetes Mellitus, Hepatitis B, Hepatitis, Chronic, Hepatitis C, Liver Cirrhosis, Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT06094777 2024-06-13

A Study of HY-0102 in Patients With Advanced Solid Tumors

Phase 1 Unknown

GastrointestinalGenitourinary

Carcinoma, Transitional Cell, Pancreatic Neoplasms, Colorectal Neoplasms

NCT05457010 2024-06-12

Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS

Phase 1 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT05103358 2024-06-03

Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

Phase 2 Unknown

Tuberous Sclerosis 1, Tuberous Sclerosis 2, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT03694600 2024-05-31

CLiMB

Liver Cirrhosis

NCT06433726 2024-05-30

A Phase l Study of By101921, an Oral PARP7 Inhibitor, in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT06434467 2024-05-30

The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma

Phase 3 Unknown

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05493800 2024-05-29

Capella

Phase 2 Unknown

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Stomatitis, Hematologic Neoplasms

NCT03275493 2024-05-28

CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05605197 2024-05-28

U87 CART in Treatment of Advanced Solid Tumor

Phase 1 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT05622162 2024-05-22

MIP7

Phase 3 Unknown

Prostatic Neoplasms

NCT04092673 2024-05-21

Zotatifin

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT05371834 2024-05-21

Microwave Treatment of Common and Plantar Warts

Phase NA Unknown

Warts

NCT04480502 2024-05-17

ENVASARC

Phase 2 Unknown

Sarcoma, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT05564858 2024-05-17

A Study of FDA022-BB05 in Subjects With Advanced Solid Malignant Tumors

Phase 1 Unknown

Neoplasms

NCT05650580 2024-05-14

TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors

Phase 1 Unknown

Lymphoma, Non-Hodgkin, Recurrence

NCT05751356 2024-05-14

TR128 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Advanced Solid Tumor

NCT06173999 2024-05-14

A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma

Phase 1/2 Unknown

Lymphoma, T-Cell, Peripheral

NCT04655118 2024-05-10

Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis

Phase 2 Unknown

Mastocytosis, Systemic, Primary Myelofibrosis

NCT06409195 2024-05-10

A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers

Phase 2 Unknown

Non-Melanoma Skin Cancers

NCT06409221 2024-05-10

VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study

Breast Neoplasms, Triple Negative Breast Neoplasms